Lipid-polyethylene glycol based nano-ocular formulation of ketoconazole

International Journal of Pharmaceutics

Volumn 495, Issue 1, 2015, Pages 276-289

  Kakkar, Shilpa ^a   Karuppayil, Sankunny Mohan ^b   Raut, Jayant S ^a   Giansanti, Fabrizio ^c   Papucci, Laura ^d   Schiavone, Nicola ^d   Kaur, Indu Pal ^a  

^a PANJAB UNIVERSITY   (India)

^b SWAMI RAMANAND TEERTH MARATHWADA UNIVERSITY   (India)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Drug delivery; Fungal eye infection; Ocular safety; Permeation; Posterior eye; Solid lipid nanoparticles

Indexed keywords

KETOCONAZOLE; MACROGOL; NANOCARRIER; SOLID LIPID NANOPARTICLE; ANTIFUNGAL AGENT; FATTY ACID; GLYCEROL BEHENATE; LIPID; MACROGOL DERIVATIVE; NANOPARTICLE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPON 90G; POLYSORBATE;

ANIMAL CELL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; AQUEOUS HUMOR; AREA UNDER THE CURVE; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; CORNEA CELL; CORNEA PERMEABILITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG PENETRATION; DRUG STORAGE; EX VIVO STUDY; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; INHIBITION ZONE; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR STABILITY; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RABBIT; RETINA CELL; SURFACE PROPERTY; TIME TO MAXIMUM PLASMA CONCENTRATION; TRANSMISSION ELECTRON MICROSCOPY; VITREOUS BODY; X RAY POWDER DIFFRACTION; ANIMAL; CELL LINE; CHEMISTRY; EYE; MEDICINAL CHEMISTRY; METABOLISM; PROCEDURES; SOLUBILITY;

ANIMALS; ANTIFUNGAL AGENTS; CELL LINE; CHEMISTRY, PHARMACEUTICAL; EYE; FATTY ACIDS; HUMANS; KETOCONAZOLE; LIPIDS; NANOPARTICLES; PARTICLE SIZE; PHOSPHATIDYLCHOLINES; POLYETHYLENE GLYCOLS; POLYSORBATES; RABBITS; SOLUBILITY;

EID: 84940975899     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.08.088     Document Type: Article

References (98)

1. D. Aggarwal, A. Garg, and I.P. Kaur Development of a topical niosomal preparation of acetazolamide: preparation and evaluation J. Pharm. Pharmacol. 56 2004 1509 1517
2. I. Ahmed, and T.F. Patton Importance of the noncorneal absorption route in topical ophthalmic drug delivery Invest. Ophthalmol. Vis. Sci. 26 1985 584 587
3. A.M. Al-Mohizea Influence of intestinal efflux pumps on the absorption and transport of furosemide Saudi Pharm. J. 18 2010 97 101
4. D. Anjana, K.A. Nair, N. Somashekara, M. Venkata, R. Sripathy, R. Yelucheri, H. Parmar, R. Upadhyay, S.R. Verma, and C.N. Ramchand Development of curcumin based ophthalmic formulation Am. J. Inf. Dis. 8 2012 41 49
5. P. Aragona, G. Di Stefano, F. Ferreri, R. Spinella, and A. Stilo Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjogren's syndrome patients Br. J. Ophthalmol. 86 2002 879 884
6. A.A. Attama, S. Reichl, and C.C. Müller-Goymann Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct Int. J. Pharm. Res. 355 2008 307 313
7. A.A. Attama, B.C. Schicke, T. Paepenmuller, and C.C. Muller-Goymann Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization Eur. J. Pharm. Biopharm. 67 2007 48 57
8. J. Barar, A.R. Javadzadeh, and Y. Omidi Ocular novel drug delivery: impacts of membranes and barriers Exp. Opin. Drug Deliv. 5 2008 567 581
9. J.G. Baxter, C. Brass, J.J. Schentag, and R.L. Slaughter Pharmacokinetics of ketoconazole administered intravenously to dogs and orally as tablet and solution to humans and dogs J. Pharm. Sci. 75 1986 443 447
10. L. Baydoun, P. Furrer, R. Gurny, and C.C. Muller-Goymann New surface-active polymers for ophthalmic formulations: evaluation of ocular tolerance Eur. J. Pharm. Biopharm. 58 2004 169 175
11. R. Bhandari, and I.P. Kaur Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles Int. J. Pharm. 441 2013 202 212
12. BP Efficacy of Antimicrobial Preservation; Appendix XVI C 1999 The Stationary Office British Pharmacopoeia London, UK A266 A268
13. C. Bucolo, F. Drago, and S. Salomone Ocular drug delivery: a clue from nanotechnology Front. Pharmacol. 3 2012 188
14. H. Bunjes, K. Westesen, and M.H.J. Koch Crystallization tendency and polymorphic transitions in triglyceride nanoparticles Int. J. Pharm. 129 1996 159 173
15. R. Cavalli, M.R. Gasco, P. Chetoni, S. Burgalassi, and M.F. Saettone Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin Int. J. Pharm. 238 2002 241 245
16. Clinical Laboratory Standards Institute (formerly NCCLS), 2002. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard, 2nd ed., M27-A2. National Committee for Clinical Laboratory Standards, Wayne, PA.
17. P.A. Constable, J.G. Lawrenson, D.E. Dolman, G.B. Arden, and N.J. Abbott P-Glycoprotein expression in human retinal pigment epithelium cell lines Exp. Eye Res. 83 2006 24 30
18. Y. Dai, R. Zhou, L. Liu, Y. Lu, J. Qi, and W. Wu Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation Int. J. Nanomed. 8 2013 1921 1933
19. R.M. Donlan, and J.W. Costerton Biofilms: survival mechanisms of clinically relevant microorganisms Clin. Microbiol. Rev. 15 2002 167 193
20. H. Fan, G. Liu, Y. Huang, Y. Li, and Q. Xia Development of a nanostructured lipid carrier formulation for increasing photo-stability and water solubility of phenylethyl resorcinol Appl. Surf. Sci. 288 2014 193 200
21. FDA, 2013. Drug Safety Communication: FDA limits usage of Nizoral (ketoconazole) oral tablets due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems. < http://www.fda.gov/Drugs/DrugSafety/ucm362415.htm > (acesssed 07.12.2014.). FDA, Inactive Ingredient Search for Approved Drug Products. < http://www.accessdata.fda.gov/scripts/cder/iig/index.Cfm > (acesssed 02.09.2014.).
22. D.H. Geroski, and H.F. Edelhauser Drug delivery for posterior segment eye disease Invest. Ophthalmol. Vis. Sci. 41 2000 961 964
23. P.S. Gill, S.R. Sauerbrunn, and M. Reading Modulated differential scanning calorimetry J. Therm. Anal. 40 1993 931 939
24. E.H. Gokce, G. Sandri, M.C. Bonferoni, S. Rossi, F. Ferrari, T. Guneri, and C. Caramella Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity Int. J. Pharm. 364 2008 76 86
25. E.H. Gokce, G. Sandri, S. Egrilmez, M.C. Bonferoni, T. Guneri, and C. Caramella Cyclosporine A-loaded solid lipid nanoparticles: ocular tolerance and in vivo drug release in rabbit eyes Curr. Eye Res. 34 2009 996 1003
26. R. Grossman, and D.A. Lee Transscleral and transcorneal iontophoresis of ketoconazole in the rabbit eye Ophthalmology 96 1989 724 729
27. H. Heiati, R. Tawashi, and N.C. Phillips Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization J. Microencapsul. 15 1998 173 184
28. J.T. Heinämäki, V.-M. Lehtola, P. Nikupaavoa, and J.K. Yliruusia The mechanical and moisture permeability properties of aqueous-based hydroxypropyl methylcellulose coating systems plasticized with polyethylene glycol Int. J. Pharm. 112 1994 191 196
29. T. Helgason, T.S. Awad, K. Kristbergsson, D.J. Mcclements, and J. Weiss Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN) J. Colloid Interf. Sci. 334 2009 75 81
30. R.K. Hemady, W. Chu, and C.S. Foster Intraocular penetration of ketoconazole in rabbits Cornea 11 1992 329 333
31. B. Heurtault, P. Saulnier, B. Pech, J.E. Proust, and J.P. Benoit Physico-chemical stability of colloidal lipid particles Biomaterials 24 2003 4283 4300
32. K. Hippalgaonkar, G.R. Adelli, K. Hippalgaonkar, M.A. Repka, and S. Majumdar Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation J. Ocul. Pharmacol. Ther. 29 2013 216 228
33. K. Hironaka, T. Fujisawa, H. Sasaki, Y. Tozuka, K. Tsuruma, M. Shimazawa, H. Hara, and H. Takeuchi Fluorescence investigation of the retinal delivery of hydrophilic compounds via liposomal eyedrops Biol. Pharm. Bull. 34 2011 894 897
34. K. Hironaka, Y. Inokuchi, Y. Tozuka, M. Shimazawa, H. Hara, and H. Takeuchi Design and evaluation of a liposomal delivery system targeting the posterior segment of the eye J. Control. Release 136 2009 247 253
35. P.M. Hughes, O. Olejnik, J.E. Chang-Lin, and C.G. Wilson Topical and systemic drug delivery to the posterior segments Adv. Drug Deliv. Rev. 57 2005 2010 2032
36. M. Iester, G.J. Orsoni, G. Gamba, M. Taffara, P. Mangiafico, S. Giuffrida, and M. Rolando Improvement of the ocular surface using hypotonic 0.4% hyaluronic acid drops in keratoconjunctivitis sicca Eye (Lond.) 14 2000 892 898
37. J. Israelachvili The different faces of poly(ethylene glycol) Proc. Natl. Acad. Sci. U. S. A. 94 1997 8378 8379
38. V. Jannin, J. Musakhanian, and D. Marchaud Approaches for the development of solid and semi-solid lipid-based formulations Adv. Drug Deliv. Rev. 60 2008 734 746
39. V. Jenning, K. Mader, and S.H. Gohla Solid lipid nanoparticles (SLN) based on binary mixtures of liquid and solid lipids: a (1)H-NMR study Int. J. Pharm. 205 2000 15 21
40. J. Jiao Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery Adv. Drug Deliv. Rev. 60 2008 1663 1673
41. K. Jores, W. Mehnert, and K. Mader Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles: a nuclear magnetic resonance and electron spin resonance study Pharm. Res. 20 2003 1274 1283
42. A. Judde, P. Villeneuve, A. Rossignol-Castera, and A. Le Guillou Antioxidant effect of soy lecithins on vegetable oil stability and their synergism with tocopherols J. Am. Oil Chem. Soc. 80 2003 1209 1215
43. V. Kakkar, S. Singh, D. Singla, and I.P. Kaur Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin Mol. Nutr. Food Res. 55 2011 495 503
44. B. Karolewicz, A. Górniak, A. Owczarek, E. Zurawska-Płaksej, A. Piwowar, and J. Pluta Thermal, spectroscopic, and dissolution studies of ketoconazole-Pluronic F127 system J. Therm. Anal. Calorim. 115 2014 2487 2493
45. M.A. Kassem, A.A. Abdel Rahman, M.M. Ghorab, M.B. Ahmed, and R.M. Khalil Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs Int. J. Pharm. 340 2007 126 133
46. I.P. Kaur, D. Aggarwal, H. Singh, and S. Kakkar Improved ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal delivery system Graefes Arch. Clin. Exp. Ophthalmol. 248 2010 1467 1472
47. I.P. Kaur, R. Bhandari, S. Bhandari, and V. Kakkar Potential of solid lipid nanoparticles for brain targeting J. Control. Release 127 2008 97 109
48. I.P. Kaur, S. Chhabra, and D. Aggarwal Role of cyclodextrins in ophthalmics Curr. Drug Del. 2004 351 360
49. I.P. Kaur, and S. Kakkar Nanotherapy for posterior eye diseases J. Control. Release 193 2014 100 112
50. I.P. Kaur, C. Rana, and H. Singh Development of effective ocular preparations of antifungal agents J. Ocul. Pharmacol. Ther. 24 2008 481 493
51. I.P. Kaur, H. Singh, and S. Kakkar Newer therapeutic vistas for antiglaucoma medicines Crit. Rev.™ Therap. Drug Carr. Syst. 28 2011 165 202
52. I.P. Kaur, and R. Smitha Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery Drug Dev. Ind. Pharm. 28 2002 353 369
53. K. Kawazu, K. Yamada, M. Nakamura, and A. Ota Characterization of cyclosporin A transport in cultured rabbit corneal epithelial cells: P-glycoprotein transport activity and binding to cyclophilin Invest. Ophthalmol. Vis. Sci. 40 1999 1738 1744
54. M. Kumar, V. Kakkar, A.K. Mishra, K. Chuttani, and I.P. Kaur Intranasal delivery of streptomycin sulfate (STRS) loaded solid lipid nanoparticles to brain and blood Int. J. Pharm. 461 2014 223 233
55. F. Laboulfie, M. Hémati, A. Lamure, and S. Diguet Effect of the plasticizer on permeability, mechanical resistance and thermal behaviour of composite coating films Powder Technol. 238 2013 14 19
56. A. Leonardi, C. Bucolo, G.L. Romano, C.B. Platania, F. Drago, G. Puglisi, and R. Pignatello Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles Int. J. Pharm. 470 2014 133 140
57. X. Li, S.F. Nie, J. Kong, N. Li, C.Y. Ju, and W.S. Pan A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers Int. J. Pharm. 363 2008 177 182
58. A.D. Logua, A.M. Faddab, C. Anchisib, A.M. Maccionib, C. Sinicob, M.L. Schivoa, and F. Alhaiquec Effects of in-vitro activity of miconazole and ketoconazole in phospholipid formulations J. Antimicrob. Chemother. 40 1997 889 893
59. T. Madheswaran, R. Baskaran, R.K. Thapa, J.Y. Rhyu, H.Y. Choi, J.O. Kim, C.S. Yong, and B.K. Yoo Design and in vitro evaluation of finasteride-loaded liquid crystalline nanoparticles for topical delivery AAPS PharmSciTech 14 2013 45 52
60. S. Mao, P. Wang, and D. Bi Investigations on 5-fluorouracil solid lipid nanoparticles (SLN) prepared by hot homogenization Pharmazie 60 2005 273 277
61. L.R. Martinez, and B.C. Fries Fungal biofilms: relevance in the setting of human disease Curr. Fungal Infect. Rep. 4 2010 266 275
62. G.A. Mathis Clinical ophthalmic pharmacology and therapeutics: ocular drug delivery K.N. Gelatt, Veterinary Ophthalmology 1999 Lippincott William & Wilkins Florida 291 297
63. S.A. Meenach, F.G. Vogt, K.W. Anderson, J.Z. Hilt, R.C. Mcgarry, and H.M. Mansour Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols Int. J. Nanomed. 8 2013 275 293
64. W. Mehnert, and K. Mäder Solid lipid nanoparticles: production, characterization and applications Adv. Drug Deliv. Rev. 47 2001 165 196
65. B. Mohanty, D.K. Majumdar, S.K. Mishra, A.K. Panda, and S. Patnaik Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery Pharm. Dev. Technol. 20 2015 458 464
66. A.S. Monem, F.M. Ali, and M.W. Ismail Prolonged effect of liposomes encapsulating pilocarpine HCl in normal and glaucomatous rabbits Int. J. Pharm. 198 2000 29 38
67. R.H. Muller, K. Mader, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177
68. R.H. Muller, M. Radtke, and S.A. Wissing Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations Adv. Drug Deliv. Rev. 54 Suppl. 1 2002 S131 S155
69. R.H. Muller, S. Runge, V. Ravelli, W. Mehnert, A.F. Thunemann, and E.B. Souto Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals Int. J. Pharm. 317 2006 82 89
70. G.G. Müller, N. Kara-Joséii, and R.S. De Castroii Antifungals in eye infections: drugs and routes of administration Rev. Bras. Oftalmol. 72 2013 132 141
71. O.K. Nag, and V. Awasthi Surface engineering of liposomes for stealth behavior Pharmaceutics 5 2013 542 569
72. R.C. Nagarwal, S. Kant, P.N. Singh, P. Maiti, and J.K. Pandit Polymeric nanoparticulate system: a potential approach for ocular drug delivery J. Control. Release 136 2009 2 13
73. T.P. O'Brien Therapy of ocular fungal infections Ophthalmol. Clin. North Am. 12 1999 33 50
74. A. Ogasawara, T. Kume, and E. Kazama Effect of oral ketoconazole on intestinal first-pass effect of midazolam and fexofenadine in cynomolgus monkeys Drug Metab. Dispos. 35 2007 410 418
75. T. Ramasamy, U.S. Khandasami, H. Ruttala, and S. Shanmugam Development of solid lipid nanoparticles enriched hydrogels for topical delivery of anti-fungal agent Macromol. Res. 20 2012 682 692
76. C. Reichardt Solvent effects on the absorption spectra of org compound Solvents and Solvent Effects in Organic Chemistry 3rd ed. 2004 Wiley-VCH Weinheim, Germany 329 387
77. Sachdeva, M., Shah, P., 2014. Surface modified multilayered nanostructures for dermal delivery. US 8647661 B1.
78. P. Saha, J.J. Yang, and V.H. Lee Existence of a p-glycoprotein drug efflux pump in cultured rabbit conjunctival epithelial cells Invest. Ophthalmol. Vis. Sci. 39 1998 1221 1226
79. A. Seyfoddin, J. Shaw, and R. Al-Kassas Solid lipid nanoparticles for ocular drug delivery Drug Deliv. 17 2010 1 23
80. S. Sharma, M. Srinivasan, and C. George The current status of Fusarium species in mycotic keratitis in South India J. Med. Microbiol. 11 1993 140 147
81. Y. Shen, and J. Tu Preparation and ocular pharmacokinetics of ganciclovir liposomes AAPS J. 9 2007 E371 E377
82. R.B. Shinde, J.S. Raut, N.M. Chauhan, and S.M. Karuppayil Chloroquine sensitizes biofilms of Candida albicans to antifungal azoles Braz. J. Infect. Dis. 17 2013 395 400
83. H.H. Sigurdsson, F. Konrásdóttir, T. Loftsson, and E. Stefánsson Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye Acta Ophthalmol. Scand. 85 2007 598 602
84. ® 888 ATO as bulk lipid and as SLN and NLC J. Microencapsul. 23 2006 417 433
85. E.B. Souto, and R.H. Muller SLN and NLC for topical delivery of ketoconazole J. Microencapsul. 22 2005 501 510
86. I. Staub, L. Flores, G. Gosmann, A. Pohmann, P.E. Froehlich, E.E.S. Schapoval, and A.M. Bergold Photostability studies of ketoconazole: isolation and structural elucidation of the main photodegradation products Lat. Am. J. Pharm. 29 2010 1100 1106
87. Y. Sultana, R. Jain, M. Aqil, and A. Ali Review of ocular drug delivery Curr. Drug Deliv. 3 2006 207 217
88. K.L. Therese, R. Bagyalakshmi, H.N. Madhavan, and P. Deepa In-vitro susceptibility testing by agar dilution method to determine the minimum inhibitory concentrations of amphotericin B, fluconazole and ketoconazole against ocular fungal isolates Indian J. Med. Microbiol. 24 2006 273 279
89. M.A. Thiel, D.J. Coster, S.D. Standfield, H.M. Brereton, C. Mavrangelos, H. Zola, S. Taylor, A. Yusim, and K.A. Williams Penetration of engineered antibody fragments into the eye Clin. Exp. Immunol. 128 2002 67 74
90. P.A. Thomas Current perspectives on ophthalmic mycoses Clin. Microbiol. Rev. 16 2003 730 797
91. P. Versura, V. Profazio, and E.C. Campos Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases Curr. Eye Res. 35 2010 553 564
92. M. Werle Natural and synthetic polymers as inhibitors of drug efflux pumps Pharm. Res. 25 2008 500 511
93. K. Westesen, H. Bunjesa, and M.H.J. Kochb Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential J. Control. Release 48 1997 223 236
94. K. Yoncheva, E. Lizarraga, and J.M. Irache Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): preparation and evaluation of their bioadhesive properties Eur. J. Pharm. Sci. 24 2005 411 419
95. J. Youshia, A.O. Kamel, A.E. Shamy, and S. Mansour Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide Int. J. Nanomed. 7 2012 2483 2496
96. L.M. Yu, J.J. Lu, I.W. Chiu, K.S. Leung, Y.W. Chan, L. Zhang, Z. Policova, M.L. Hair, and A.W. Neumann Poly(ethylene glycol) enhances the surface activity of a pulmonary surfactant Colloids Surf. B Biointerf. 36 2004 167 176
97. H. Zhang, M. Yao, R.A. Morrison, and S. Chong Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats Arch. Pharm. Res. 26 2003 768 772
98. J. Zhang, L. Wang, C. Gao, L. Zhang, and H. Xia Ocular pharmacokinetics of topically-applied ketoconazole solution containing hydroxypropyl beta-cyclodextrin to rabbits J. Ocul. Pharmacol. Ther. 24 2008 501 506